Teratogen update: Pseudoephedrine

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 6, 2006, Pages 445-452

  Werler, Martha M ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DECONGESTIVE AGENT; EPHEDRINE; NAPHAZOLINE; OXYMETAZOLINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; TETRYZOLINE; XYLOMETAZOLINE;

ANIMAL MODEL; AORTA ARCH ANOMALY; AORTA COARCTATION; BIRTH DEFECT; BLEEDING; CARDIOVASCULAR MALFORMATION; CASE CONTROL STUDY; CHICK; CIGARETTE SMOKING; CLUBFOOT; COHORT ANALYSIS; CONGENITAL MALFORMATION; DRUG EFFECT; EAR MALFORMATION; ECTRODACTYLY; EPHEDRA; EPHEDRA SINICA; EYE MALFORMATION; FIRST TRIMESTER PREGNANCY; GASTROSCHISIS; GOLDENHAR SYNDROME; HEART VENTRICLE SEPTUM DEFECT; HEMATOMA; HEMIFACIAL MICROSOMIA; HEMODYNAMICS; HETEROTAXY SYNDROME; HUMAN; HYDRANENCEPHALY; INTESTINE ATRESIA; INTESTINE STENOSIS; LIMB MALFORMATION; NONHUMAN; NOSE AIRWAY RESISTANCE; PES EQUINOVARUS; POLAND SYNDROME; PORENCEPHALY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RABBIT; RAT; REVIEW; SKIN APLASIA; SYSTEMATIC REVIEW; TERATOGENICITY; UTERUS BLOOD FLOW; VASOCONSTRICTION;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; EPHEDRINE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

ANIMALIA;

EID: 33748284712     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20255     Document Type: Review

References (73)

1. Addis A, Moretti ME, Ahmed Syed F, et al. 2001. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 15:341-369.
2. Aselton P, Jick H, Milunsky A, et al. 1985. First-trimester drug use and congenital disorders. Obstet Gynecol 65:451-455.
3. Barker S, Chesney D, Miedzybrodzka Z, Maffulli N. 2003. Genetics and epidemiology of idiopathic congenital talipes equinovarus. J Pediatr Orthop 23:265-272.
4. Bateman DN, McElhatton PR, Dickinson D, et al. 2004. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. Eur J Clin Pharmacol 60:635-641.
5. Bavinck JN, Weaver DD. 1986. Subclavian artery supply disruption sequence: hypothesis of a vascular etiology for Poland, Klippel-Feil, and Mobius anomalies. Am J Med Genet 23:903-918.
6. Bents RT, Tokish JM, Goldberg L. 2004. Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players. Phys Sportsmed 32:30-34.
7. Brent RL, Franklin JB. 1960. Uterine vascular clamping: new procedures for the study of congenital malformations. Science 132:89-91.
8. Brent RL, Holmes LB. 1988. Clinical and basic science lessons from the thalidomide tragedy: what have we learned about the causes of limb defects? Teratology 38:241-251.
9. Cambiaghi S, Schiera A, Tasin L, Gelmetti C. 2001. Aplasia cutis congenita in surviving co-twins: four unrelated cases. Pediatr Dermatol 18:511-515.
10. Chernoff N, Grabowski CT. 1971. Responses of the rat foetus to maternal injections of adrenaline and vasopressin. Br J Pharmacol 43:270-278.
11. Clark EB. 1987. Mechanisms in the pathogenesis of congenital heart defects. Pierpont MEM, Moller JH, editors. The Genetics of Cardiovascular disease. Boston: Martinus-Nijoff; 3-10
12. Czeizel AE, Kodaj I, Lenz W. 1994. Smoking during pregnancy and congenital limb deficiency. BMJ 308:1473-1476.
13. Delahunt CS, Lassen LJ. 1964. Thalidomide syndrome in monkeys. Science 146:1300-1305.
14. Dietz FR. 1985. On the pathogenesis of clubfoot. Lancet 1:388-390.
15. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. 1997. Genetic and environmental risk factors of major cardiovascular malformations. The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Furura Publishing.
16. Frank AA, Thompson DJ, Kazacos EA. 1989. Teratogenicity of 3,3-dimethyl-1-phenyltriazene in the rat: gross malformations including micrognathism. Teratology 39:53-61.
17. Fujinaga M, Baden JM. 1991. Critical period of rat development when sidedness of asymmetric body structures is determined. Teratology 44:453-462.
18. Fujinaga M, Lowe LA, Kuehn MR. 2000. alpha(1)-Adrenergic stimulation perturbs the left-right asymmetric expression pattern of nodal during rat embryogenesis. Teratology 62:317-324.
19. Catling RR. 1962. The effect of sympathomimetic agents on the chick embryo. Am J Pathol 40:113-127.
20. Gilbert-Barness E, Drut RM. 2000. Association of sympathomimetic drugs with malformations. Vet Hum Toxicol 42:168-171.
21. Glineur R, Louryan S, Lemaitre A, et al. 1999. Cranio-facial dysmorphism: experimental study in the mouse, clinical applications. Surg Radiol Anat 21:41-47.
22. Goldbaum G, Daling J, Milham S. 1990. Risk factors for gastroschisis. Teratology 42:397-403.
23. Haddow JE, Palomaki GE, Holman MS. 1993. Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology 47:225-228.
24. Heinonen OP, Slone D, Shapiro S. 1977. Birth defects and drugs in pregnancy. Littleton, MA: PSG Publishing.
25. Hodach RJ, Gilbert EF, Fallon JF. 1974. Aortic arch anomalies associated with the administration of epinephrine in chick embryos. Teratology 9:203-209.
26. Hoyme HE, Higginbottom MC, Jones KL. 1981a. Vascular etiology of disruptive structural defects in monozygotic twins. Pediatrics 67:288-291.
27. Hoyme HE, Higginbottom MC, Jones KL. 1981b. The vascular pathogenesis of gastroschisis: intrauterine interruption of the omphalomesenteric artery. J Pediatr 98:228-231.
28. Hoyme HE, Jones KL, Van Allen MI, et al. 1982. Vascular pathogenesis of transverse limb reduction defects. J Pediatr 101:839-843.
29. Hoyme HE, Jones KL, Dixon SD, et al. 1990. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747.
30. Jick H, Holmes LB, Hunter JR, et al. 1981. First-trimester drug use and congenital disorders. JAMA 246:343-346.
31. Jung JH, Graham JM, Jr, Schultz N, Smith DW. 1984. Congenital hydranencephaly/porencephaly due to vascular disruption in monozygotic twins. Pediatrics 73:467-469.
32. Kallen K. 1997a. Maternal smoking and urinary organ malformations. Int J Epidemiol 26:571-574.
33. Kallen K. 1997b. Maternal smoking during pregnancy and limb reduction malformations in Sweden. Am J Public Health 87:29-32.
34. Kallen BAJ, Olausson PO. 2006. Use of oral decongestants during pregnancy and delivery outcome. Am J Obstet Gynecol 194:480-485.
35. Khera KS. 1976. Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats. Teratology 14:21-27.
36. Kimmel CA, Wilson JG, Schumacher HJ. 1971. Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats. Teratology 4:15-24.
37. Komuro H, Watanabe M, Matoba K, Kaneko M. 2003. Gastroschisis with omphalomesenteric artery remnant, colonic atresia, and arthrogryposis multiplex congenita. Eur J Pediatr Surg 13;334-336.
38. Kozer E, Nikfar S, Costei A, et al. 2002. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol 187:1623-1630.
39. Li P, Tong C, Eisenach JC. 1996. Pregnancy and ephedrine increase the release of nitric oxide in ovine uterine arteries. Anesth Analg 82:288-293.
40. Louryan S, Heymans O, Goffard JC. 1995. Ear malformations in the mouse embryo following maternal administration of triazene, with clinical implications. Surg Radiol Anat 17:59-63.
41. Louw JH, Barnard CN. 1955. Congenital intestinal atresia; observations on its origin. Lancet 269:1065-1067.
42. Magness RR, Rosenfeld CR, 1986. Systemic and uterine responses to alpha-adrenergic stimulation in pregnant and nonpregnant ewes. Am J Obstet Gynecol 155:897-904.
43. Matsuoka R, Gilbert EF, Bruyere HJ Jr, et al. 1987. Experimentally induced cardiovascular malformations in the chick embryo. Part II. Teratogenic effect of Tedral (theophylline, ephedrine, and phenobarbital) on cardiac development in chick embryos. Birth Defects Orig Artic Ser 23:449-452.
44. Mitchell AA, Cottler LB, Shapiro S. 1986. Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123:670-676.
45. Mitchell AA. 2006. Studies of drug-induced birth defects [Chapter 32]. In: Strom BL, editor. Pharmacoepidemiology, 4th ed. New York: Wiley; 501-514.
46. Neal GS, Hankins GD. 1992. Left microtia in one monozygotic twin. A case report. J Reprod Med 37:375-377.
47. Nishikawa T, Bruyere HJ, Jr, Takagi Y, et al. 1985. Cardiovascular teratogenicity of ephedrine in chick embryos. Toxicol Lett 29:59-63.
48. Orioli IM, Castilla EE. 2000. Epidemiological assessment of misoprostol teratogenicity. BJOG 107:519-523.
49. Pentel P. 1984. Toxicity of over-the-counter stimulants. JAMA 252;1898-1903.
50. Perez-Aytes A, Graham JM, Hersh JH, et al. 1993. Urethral obstruction sequence and lower limb deficiency: evidence for the vascular disruption hypothesis. J Pediatr 123:398-405.
51. Phelan MC, Geer JS, Blackburn WR. 1998. Vascular anastomoses leading to amelia and cutis aplasia in a dizygotic twin pregnancy. Clin Genet 53:126-130.
52. Poswillo D. 1973. The pathogenesis of the first and second branchial arch syndrome. Oral Surg Oral Med Oral Pathol 35:302-328.
53. Robinson LK, Hoyme HE, Edwards DK, Jones KL. 1987. Vascular pathogenesis of unilateral craniofacial defects. J Pediatr 111:236-239.
54. Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. 1979. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 109:433-439.
55. Rowe GG, Castillo CA, Crumpton CW, Maxwell GM. 1965. Systemic and coronary hemodynamic effects of pseudoephedrine. Proc Soc Exp Biol Med 118:682-684.
56. Schinzel AA, Smith DW, Miller JR. 1979. Monozygotic twinning and structural defects. J Pediatr 95:921-930.
57. Skelly AC, Holt VL, Mosca VS, Alderman BW. 2002. Talipes equinovarus and maternal smoking: a population-based case-control study in Washington state. Teratology 6691-100.
58. Smith CV, Rayburn WF, Anderson JC, et al. 1990. Effect of a single dose of oral pseudoephedrine on uterine and fetal Doppler blood flow. Obstet Gynecol 76(Pt 1):803-806.
59. Snyder CL, Miller KA, Sharp RJ, et al. 2001. Management of intestinal atresia in patients with gastroschisis. J Pediatr Surg 36:1542-1545.
60. Tong C, Eisenach JC. 1992. The vascular mechanism of ephedrine's beneficial effect on uterine perfusion during pregnancy. Anesthesiology 76:792-798.
61. Tongjaroenbuangam W, Meksuriyen D, Govitrapong P, et al. 1998. Drug discrimination analysis of pseudoephedrine in rats. Pharmacol Biochem Behav 59:505-510.
62. Torfs CP, Katz EA, Bateson TF, et al. 1996. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54:84-92.
63. Ugen KE, Scott WJ, Jr. 1987. Reduction of uterine blood flow by phenylephrine, an alpha-adrenergic agonist, in the day 11 pregnant rat: relationship to potentiation of acetazolamide teratogenesis. Teratology 36:133-141.
64. Van Allen MI. 1981. Fetal vascular disruptions: mechanisms and some resulting birth defects. Pediatr Ann 10:219-233.
65. Vargas FR, Schuler-Faccini L, Brunoni D, et al. 2000. Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. Am J Med Genet 95:302-306.
66. Warkany J, Takacs E. 1959. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol 35:315-331.
67. Webster WS, Brown-Woodman PD. 1990. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology 41;689-97.
68. Werler MM, Mitchell AA, Shapiro S. 1992. First trimester maternal medication use in relation to gastroschisis. Teratology 45:361-367.
69. Werler MM, Sheehan JE, Mitchell AA. 2002. Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155:26-31.
70. Werler MM, Sheehan JE, Hayes C, et al. 2004. Vasoactive exposures, vascular events, and hemifacial microsomia. Birth Defects Res A Clin Mol Teratol 70:389-395.
71. Werler MM, Mitchell AA, Hernandez-Diaz S, Honein MA. 2005. Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol 193(Pt 1):771-777.
72. Wilson JG, Gavan JA. 1967. Congenital malformations in nonhuman primates: spontaneous and experimentally induced. Anat Rec 158:99-109.
73. Zierler S, Rothman KJ. 1985. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 313:347-352.